Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antibiotic resistant infections 'continue to rise'
antibiotics
"Antimicrobial resistance is a major threat to the delivery of healthcare across the globe".
New report issued by Public Health England

The number of antibiotic resistant infections is continuing to rise, according to a new report by Public Health England (PHE).

Key findings:
  • Bloodstream infections caused by Escherichia coli rose by 15.6 per cent between 2010 and 2014. The proportion that were drug resistant remained constant
  • Bloodstream infections caused by Klebsiella pneumoniae rose by 20.8 per cent
  • Streptococcus pneumoniae bloodstream infections fell by 23 per cent, which is thought to be due to pneumococcal vaccination rates

On a positive note, the report shows a drop in the number of antibiotic prescriptions dispensed in primary care.

Despite this, the total antibiotic consumption in primary care actually increased by 6.5 per cent between 2011 and 2014. PHE says this suggests longer courses and/or higher dosages are being prescribed in general practice.

Use of broad spectrum antibiotics - which are most likely to drive antibiotic resistance - has fallen in primary care to 8.5 per cent. As a result, England is now the lowest prescriber of some of these drugs in the European Union.

The figures show that the highest proportion of these drugs are prescribed in secondary care. PHE says hospitals need to focus their efforts to ensure they prescribe broad-spectrum antibiotics for the right reasons and the right duration.

Commenting on the report, Dr Mike Durkin, NHS England director of patient safety, said: "Antimicrobial resistance is a major threat to the delivery of healthcare across the globe and these findings clearly show the need for both clinicians and patients to act now and do all they can to behave as responsible stewards of the use of antimicrobial medications.

"As one of the largest healthcare providers in the world, it is vital the NHS is seen to lead that fight against the global problem of antimicrobial resistance so these immensely important medicines can be preserved for now and future generations."

This new data has come from the second annual report of PHE's English Surveillance Programme for Antimicrobial Utilisation and Resistance. To read the report, visit: https://www.gov.uk/government/news/espaur-report-reveals-continued-rise-in-antibiotic-resistant-infections

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.